153 related articles for article (PubMed ID: 28686629)
1. The characteristics of screening and confirmatory test results for HIV in Xi'an, China.
Wang L; Zhou KH; Zhao HP; Wang JH; Zheng HC; Yu Y; Chen W
PLoS One; 2017; 12(7):e0180071. PubMed ID: 28686629
[TBL] [Abstract][Full Text] [Related]
2. HIV infection in Xi'an, China: epidemic characterization, risk factors to false positives and potential utility of the sample-to-cutoff index to identify true positives using Architect HIV Ag/Ab combo.
Wang L; Xiao Y; Tian XD; Ruan JX; Chen W; Yu Y
Antimicrob Resist Infect Control; 2019; 8():9. PubMed ID: 30651975
[TBL] [Abstract][Full Text] [Related]
3. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
[TBL] [Abstract][Full Text] [Related]
4. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
[TBL] [Abstract][Full Text] [Related]
6. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
[TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the vitros hiv combo 4th generation test for the identification of HIV infections.
De Paschale M; Manco MT; Cianflone A; Belvisi L; Cagnin D; Cerulli T; Paganini A; Agrappi C; Mirri P; Clerici P
J Clin Virol; 2018 Nov; 108():77-82. PubMed ID: 30266004
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012-2018.
Liu P; Tang L; Kong WH; Zhu ZR; Xiao P; Wang X; Zhou W; Liu MQ
PLoS One; 2020; 15(9):e0238282. PubMed ID: 32915788
[TBL] [Abstract][Full Text] [Related]
10. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
[TBL] [Abstract][Full Text] [Related]
11. HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferral.
Stoyanov E; Gozlan Y; Wax M; Levin E; Shvartz L; Shinar E; Mendelson E; Mor O
Transfusion; 2019 Jun; 59(6):2054-2060. PubMed ID: 30893485
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.
Muthukumar A; Alatoom A; Burns S; Ashmore J; Kim A; Emerson B; Bannister E; Ansari MQ
Lab Med; 2015; 46(2):84-9; quiz e28-9. PubMed ID: 25918186
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
[TBL] [Abstract][Full Text] [Related]
15. Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay - evaluation of a new HIV assay.
Wang T; Li D; Yan K; Yuan Y; Yang T; Du X; Yan X; Tao C; Wang L
Int J STD AIDS; 2014 Mar; 25(4):267-72. PubMed ID: 23970655
[TBL] [Abstract][Full Text] [Related]
16. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
Dubravac T; Gahan TF; Pentella MA
J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
[TBL] [Abstract][Full Text] [Related]
17. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
[TBL] [Abstract][Full Text] [Related]
18. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.
Chacón L; Mateos ML; Holguín Á
J Clin Virol; 2017 Jul; 92():11-13. PubMed ID: 28501753
[TBL] [Abstract][Full Text] [Related]
19. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
[TBL] [Abstract][Full Text] [Related]
20. Programmatic evaluation of a combined antigen and antibody test for rapid HIV diagnosis in a community and sexual health clinic screening programme.
Taegtmeyer M; MacPherson P; Jones K; Hopkins M; Moorcroft J; Lalloo DG; Chawla A
PLoS One; 2011; 6(11):e28019. PubMed ID: 22132195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
